| Company Name: |
YantaiBio |
| Tel: |
13758194781; 13758194781 |
| Email: |
764619768@qq.com |
| Company Name: |
Fuan Bio |
| Tel: |
15002819872 |
| Email: |
2845971812@qq.com |
|
| Product Name: | GLR-19 | | Synonyms: | GLR-19;L-Arginine, glycyl-L-leucyl-L-arginyl-L-arginyl-L-leucyl-L-leucylglycyl-L-arginyl-L-leucyl-L-leucyl-L-arginyl-L-arginyl-L-leucylglycyl-L-arginyl-L-leucyl-L-leucyl-L-leucyl- | | CAS: | 1225014-05-0 | | MF: | C102H194N40O20 | | MW: | 2300.89 | | EINECS: | | | Product Categories: | | | Mol File: | 1225014-05-0.mol |  |
| | GLR-19 Chemical Properties |
| density | 1.387±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | Sequence | Gly-Leu-Arg-Arg-Leu-Leu-Gly-Arg-Leu-Leu-Arg-Arg-Leu-Gly-Arg-Leu-Leu-Leu-Arg |
| | GLR-19 Usage And Synthesis |
| Uses | GLR-19 is an anti-HIV peptide. GLR-19 also has antiviral activity against HSV-2[1][2]. | | References | [1] Mishra B, et al. The Importance of Amino Acid Composition in Natural AMPs: An Evolutional, Structural, and Functional Perspective. Front Immunol. 2012 Jul 31;3:221. DOI:10.3389/fimmu.2012.00221
[2] Guangshun Wang, et al. De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures. Journal of AIDS & Clinical Research. 2011, S2 |
| | GLR-19 Preparation Products And Raw materials |
|